Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-22-021815

Chief Executive Officer sold 86,877 shares at an average $23.23 ($2,018,344)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kirn David Chief Executive Officer 2022-12-15 Sale −31,433 $23.56 $740,568 1,968,567 D
Kirn David Chief Executive Officer 2022-12-15 Sale −1,500 $24.13 $36,199 1,967,067 D
Kirn David Chief Executive Officer 2022-12-16 Sale −27,595 $22.66 $625,372 1,939,472 D
Kirn David Chief Executive Officer 2022-12-16 Sale −26,349 $23.39 $616,206 1,913,123 D
Open-market sales · 86,877 sh · avg $23.23 · $2,018,344
Loading xslF345X03/doc1.xml…